Concert Pharmaceuticals appoints two vice presidents
Ms. Boisclair joins Concert with more than 30 years of regulatory affairs experience in the biopharmaceutical industry across multiple therapeutic areas.
Prior to joining Concert, Ms. Boisclair was Vice President, Regulatory Affairs, at Forum Pharmaceuticals.
She held management roles at several companies including Insmed, Agennix, OSI Pharmaceuticals, Genzyme Corporation, Immulogic Pharmaceuticals and Parexel International.
Ms. Boisclair also worked in regulatory at Searle Pharmaceuticals and Glaxo in the U.K.
She received a Bachelor of Science Honors Degree in Biochemistry from the University of York in the U.K.
Mr. Weintraub joins Concert with more than 17 years of commercial experience in the biopharmaceutical industry, including strategic product assessment, brand positioning, commercial life cycle management, and sales and marketing.
Prior to joining Concert, Mr. Weintraub was Vice President of Product Strategy and Marketing at Forum Pharmaceuticals.
He also served as Senior Director of Marketing at Sunovion Pharmaceuticals and held sales and marketing positions at AstraZeneca.
Mr. Weintraub holds a B.S. in Finance and Marketing from Florida State University and an M.B.A. in Health Administration and Policy from University of Miami. ■
LATEST MOVES FROM Massachusetts
- bluebird bio appoints Mary Lynne Hedley to board
- Welch's names Lesya Lysyj president, US
- Liberty Mutual appoints Gregg Cunningham as vice president
- Voyager Therapeutics appoints Matthew P. Ottmer as COO
- Ocular Therapeutix appoints Michael Goldstein as CMO
More inside POST